跳至主要内容
临床试验/ACTRN12621000678897
ACTRN12621000678897已完成未知

The effect of micronutrient supplementation on inflammation in metabolic syndrome

niversity of Otago, Dunedin0 个研究点目标入组 72 人开始时间: 2021年6月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1 - Male or female aged greater than or equal to 18 years
  • 2 - Central/abdominal obesity (i.e. waist circumference greater than or equal to 94 cm for males, greater than or equal to 80 cm for females or BMI greater than or equal to 30 kg/m2)
  • 3 - And any two of the below:
  • a) Hyperglycemia (i.e. fasting glucose greater than or equal to 5.6 mmol/L or taking medication for this condition)
  • b) Raised triglycerides (i.e. TG greater than or equal to 1.7 mmol/L or taking medication for this condition)
  • c) Lowered HDL (HDL less than 1.0 mmol/L males, less than 1.3 mmol/L females or taking medication for this condition)
  • d) Hypertension (i.e. blood pressure greater than 130 systolic or greater than 86 diastolic or taking medication for this condition)
  • 4 - CRP greater than 3mg/L (i.e. high risk of cardiovascular disease - CVD)

排除标准

  • 1 - Acute illness within previous 2 weeks
  • 2 - Taking anti-inflammatory medication (e.g. corticosteroids)
  • 3 - Suffering from inflammatory conditions (e.g. active malignancy, rheumatoid arthritis, lupus, inflammatory bowel disease)
  • 4 - Pregnant or breastfeeding
  • 5 - Taking micronutrient (vitamin/mineral) supplements

研究者

发起方
niversity of Otago, Dunedin

相似试验